A LONG-TERM OPEN-LABEL EXTENSION STUDY OF LERSIVIRINE FOR THE TREATMENT OF HIV-1 INFECTION

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020860-39

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the long-term safety and efficacy of lersivirine in subjects who have completed treatment with lersivirine in the parent protocols.


Critère d'inclusion

  • Treatment of HIV-1 infection in combination with other agents in antiretroviral treatment naive and antiretroviral treatment-experienced subjects